• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer.结直肠癌肿瘤生长模式的预后意义及分子相关性。
Ann Surg Oncol. 2012 Jun;19(6):1944-53. doi: 10.1245/s10434-011-2174-5. Epub 2011 Dec 22.
2
Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.结直肠癌中印戒细胞和黏液成分的预后意义及分子特征
Ann Surg Oncol. 2015 Apr;22(4):1226-1235. doi: 10.1245/s10434-014-4159-7. Epub 2014 Oct 18.
3
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.胰岛素样生长因子 2 信使 RNA 结合蛋白 3(IGF2BP3)是结直肠癌预后不良的标志物。
Eur J Cancer. 2012 Dec;48(18):3405-13. doi: 10.1016/j.ejca.2012.06.021. Epub 2012 Jul 26.
4
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.近端结肠 BRAF 突变、微卫星稳定型腺癌:一种侵袭性腺癌,具有不良的生存预后、黏液分化和不良的形态学特征。
Am J Surg Pathol. 2012 May;36(5):744-52. doi: 10.1097/PAS.0b013e31824430d7.
5
Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.结直肠印戒细胞癌中的杂合性缺失、异常甲基化、BRAF 突变和 KRAS 突变。
Mod Pathol. 2012 Jul;25(7):1040-7. doi: 10.1038/modpathol.2012.44. Epub 2012 Apr 20.
6
SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.SIRT1组蛋白去乙酰化酶表达与结直肠癌中的微卫星不稳定性及CpG岛甲基化表型相关。
Mod Pathol. 2009 Jul;22(7):922-32. doi: 10.1038/modpathol.2009.49. Epub 2009 May 8.
7
TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.TGFBR2 和 BAX 单核苷酸重复突变、微卫星不稳定性与 1072 例结直肠癌的预后。
PLoS One. 2011;6(9):e25062. doi: 10.1371/journal.pone.0025062. Epub 2011 Sep 20.
8
Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.CDH1(E-钙黏蛋白)表达缺失与肿瘤浸润性生长和淋巴结转移相关。
Br J Cancer. 2016 Jan 19;114(2):199-206. doi: 10.1038/bjc.2015.347. Epub 2016 Jan 7.
9
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.结直肠癌中KRAS密码子61和密码子146突变的临床病理、分子及预后相关性分析:队列研究与文献综述
Mol Cancer. 2014 May 31;13:135. doi: 10.1186/1476-4598-13-135.
10
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.转移性结直肠癌黏液分化的预后意义可通过独特的分子和临床病理特征来解释。
Clin Colorectal Cancer. 2018 Dec;17(4):e699-e709. doi: 10.1016/j.clcc.2018.07.005. Epub 2018 Jul 17.

引用本文的文献

1
Clinicopathologic features of superficial esophageal squamous cell carcinoma in different infiltrative growth pattern.不同浸润生长模式下食管浅表鳞状细胞癌的临床病理特征
Front Oncol. 2025 Jul 30;15:1512433. doi: 10.3389/fonc.2025.1512433. eCollection 2025.
2
Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.三种结直肠癌侵袭性肿瘤前沿组织病理学评分方法的研究
J Pathol Clin Res. 2025 May;11(3):e70031. doi: 10.1002/2056-4538.70031.
3
Inclusion of tumor periphery in radiomics analysis of magnetic resonance images does not improve predictions of preoperative therapy response in patients with rectal cancer.在直肠癌患者的磁共振图像放射组学分析中纳入肿瘤周边区域并不能改善对术前治疗反应的预测。
Abdom Radiol (NY). 2025 Feb 5. doi: 10.1007/s00261-025-04815-0.
4
Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning.通过深度学习探索结直肠癌患者病理图像中的预后生物标志物。
J Pathol Clin Res. 2024 Nov;10(6):e70003. doi: 10.1002/2056-4538.70003.
5
The benefit of adjuvant chemotherapy in pathological T1-3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data.辅助化疗在病理T1-3N0M0直肠黏液腺癌中的益处:基于大人群数据长期生存分析的生存结局无改善
J Gastrointest Oncol. 2024 Aug 31;15(4):1568-1579. doi: 10.21037/jgo-24-271. Epub 2024 Aug 17.
6
Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma.近端结肠黏液腺癌的临床病理特征及预后分析。
Sci Rep. 2024 Aug 12;14(1):18682. doi: 10.1038/s41598-024-69916-0.
7
Cancer spreading patterns based on epithelial-mesenchymal plasticity.基于上皮-间质可塑性的癌症扩散模式。
Front Cell Dev Biol. 2024 Apr 11;12:1259953. doi: 10.3389/fcell.2024.1259953. eCollection 2024.
8
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.微卫星稳定(MSS)和不稳定(MSI)III 期结直肠癌中 KRAS 外显子 2 亚突变和 BRAF V600E 突变的不同预后价值:ACCENT/IDEA 七个试验的汇总分析。
Ann Oncol. 2023 Nov;34(11):1025-1034. doi: 10.1016/j.annonc.2023.08.006. Epub 2023 Aug 23.
9
Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer.人工智能辅助分析结直肠癌浸润边缘的肿瘤免疫相互作用。
Ann Med. 2023 Dec;55(1):2215541. doi: 10.1080/07853890.2023.2215541.
10
Artificial intelligence for quantifying Crohn's-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer.用于量化结直肠癌中克罗恩样淋巴样反应和肿瘤浸润淋巴细胞的人工智能
Comput Struct Biotechnol J. 2022 Oct 6;20:5586-5594. doi: 10.1016/j.csbj.2022.09.039. eCollection 2022.

本文引用的文献

1
Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.CTNNB1(β-连环蛋白)改变、体重指数和体力活动与结直肠癌患者生存率的关联
JAMA. 2011 Apr 27;305(16):1685-94. doi: 10.1001/jama.2011.513.
2
Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.Msi-1 是结肠癌患者生存的预测因子和新的治疗靶点。
Ann Surg Oncol. 2011 Jul;18(7):2074-83. doi: 10.1245/s10434-011-1567-9. Epub 2011 Mar 26.
3
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer.BRAF 突变是晚期和复发性结直肠癌强有力的预后因素。
Br J Cancer. 2011 Mar 1;104(5):856-62. doi: 10.1038/bjc.2011.19. Epub 2011 Feb 1.
4
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.结直肠癌的组织病理学预后因素与局部免疫反应状态有关。
J Clin Oncol. 2011 Feb 20;29(6):610-8. doi: 10.1200/JCO.2010.30.5425. Epub 2011 Jan 18.
5
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.肿瘤浸润性 T 细胞亚群、结直肠癌的分子变化与预后:队列研究与文献回顾
J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774.
6
Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma.E-钙黏蛋白和 MUC2 表达缺失与 II 期和 III 期结直肠癌患者的不良预后相关。
Ann Surg Oncol. 2011 Mar;18(3):711-9. doi: 10.1245/s10434-010-1338-z. Epub 2010 Sep 24.
7
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.BRAF V600E 突变是 II 期和 III 期结肠癌患者生存的独立预后因素。
Ann Oncol. 2010 Dec;21(12):2396-2402. doi: 10.1093/annonc/mdq258. Epub 2010 May 25.
8
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.错配修复缺陷作为氟尿嘧啶为基础的辅助治疗结肠癌无效的预测标志物。
J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24.
9
Microsatellite instability in colorectal cancer.结直肠癌中的微卫星不稳定性。
Gastroenterology. 2010 Jun;138(6):2073-2087.e3. doi: 10.1053/j.gastro.2009.12.064.
10
Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model.结直肠癌的微卫星不稳定性可以通过常规病理检查来预测。一项前瞻性多中心研究和对 615 例病例的统计分析,巩固了我们之前提出的逻辑回归模型。
Virchows Arch. 2010 May;456(5):533-41. doi: 10.1007/s00428-010-0896-6.

结直肠癌肿瘤生长模式的预后意义及分子相关性。

Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer.

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

出版信息

Ann Surg Oncol. 2012 Jun;19(6):1944-53. doi: 10.1245/s10434-011-2174-5. Epub 2011 Dec 22.

DOI:10.1245/s10434-011-2174-5
PMID:22189472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3321113/
Abstract

BACKGROUND

Infiltrative growth pattern at the tumor margin has been associated with shorter patient survival. However, little is known about the prognostic significance of tumor growth pattern, independent of tumoral molecular alterations and other histologic features.

METHODS

Utilizing a database of 1139 colon and rectal cancer patients in two prospective cohort studies, histologic features including tumor growth pattern, tumor differentiation, lymphocytic reaction, mucinous component, and signet ring cell component were recorded by a single pathologist. Cox proportional hazard model was used to compute mortality hazard ratio, adjusting for clinical, pathologic, and tumor molecular features, including microsatellite instability, the CpG island methylator phenotype, long interspersed nucleotide element 1 (LINE-1) methylation, and KRAS, BRAF, and PIK3CA mutations.

RESULTS

Among 1139 colorectal cancers, we observed expansile growth pattern in 372 tumors (33%), intermediate growth pattern in 610 tumors (54%), and infiltrative growth pattern in 157 tumors (14%). Compared to patients with expansile growth pattern, those with infiltrative growth pattern experienced shorter cancer-specific survival (log rank P < 0.0001; multivariate hazard ratio 1.74; 95% confidence interval 1.22-2.47) and overall survival (log rank P < 0.0001; multivariate hazard ratio 1.78; 95% confidence interval 1.33-2.39). The prognostic association of infiltrative growth pattern was confined to patients with stage I-III disease (P (interaction) with stage = 0.0001).

CONCLUSIONS

Infiltrative growth pattern was associated with worse prognosis among stage I-III colorectal cancer patients, independent of other clinical, pathologic, and molecular characteristics.

摘要

背景

肿瘤边缘的浸润性生长模式与患者生存时间缩短有关。然而,关于肿瘤生长模式的预后意义,独立于肿瘤分子改变和其他组织学特征,人们知之甚少。

方法

利用两个前瞻性队列研究中 1139 例结肠癌和直肠癌患者的数据库,由一名病理学家记录组织学特征,包括肿瘤生长模式、肿瘤分化、淋巴细胞反应、黏液成分和印戒细胞成分。采用 Cox 比例风险模型计算死亡率风险比,调整临床、病理和肿瘤分子特征,包括微卫星不稳定性、CpG 岛甲基化表型、长散布核元件 1(LINE-1)甲基化、KRAS、BRAF 和 PIK3CA 突变。

结果

在 1139 例结直肠癌中,我们观察到 372 例(33%)肿瘤呈膨胀性生长模式,610 例(54%)肿瘤呈中间性生长模式,157 例(14%)肿瘤呈浸润性生长模式。与膨胀性生长模式的患者相比,浸润性生长模式的患者癌症特异性生存率更短(对数秩检验 P<0.0001;多变量风险比 1.74;95%置信区间 1.22-2.47)和总生存率更短(对数秩检验 P<0.0001;多变量风险比 1.78;95%置信区间 1.33-2.39)。浸润性生长模式的预后相关性仅限于 I-III 期疾病患者(P(与分期的交互作用)=0.0001)。

结论

浸润性生长模式与 I-III 期结直肠癌患者的预后较差相关,独立于其他临床、病理和分子特征。